SKI Market

Indian Indices

Nifty

25,509.70 -87.95
(-0.34%)

Sensex

83,097.49 -213.52
( -0.26%)

Bank Nifty

57,554.25 -272.80
( -0.47%)

Nifty IT

35,337.60 63.05
( 0.18%)

Global Indices

Nasdaq

46,931.02 -400.98
(-0.85%)

Dow Jones

6,741.06 -76.23
(-1.12%)

Hang Seng

50,848.14 635.87
(1.27%)

Nikkei 225

9,736.38 -40.70
(-0.42%)

Forex

USD-INR

88.65 -0.03
(-0.04%)

EUR-INR

101.82 -0.15
(-0.14%)

GBP-INR

115.54 -0.38
(-0.33%)

JPY-INR

0.58 0.00
(-0.08%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

299.4743419

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

31.18

731.05

EPS(TTM)

Face Value()

Div & Yield %

49.65

0.05

Back

b n rathi securities ltd

Tarmat consolidated net profit rises 25.45% in the June 2025 quarter

Aug 15,2025

Net profit of Tarmat rose 25.45% to Rs 0.69 crore in the quarter ended June 2025 as against Rs 0.55 crore during the previous quarter ended June 2024. Sales rose 14.51% to Rs 24.94 crore in the quarter ended June 2025 as against Rs 21.78 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	24.94	21.78	15
OPM %	4.45	4.27	-
PBDT	0.93	0.70	33
PBT	0.64	0.52	23
NP	0.69	0.55	25

25,509.70 -87.95 (-0.34%)

83,097.49 -213.52 ( -0.26%)

57,554.25 -272.80 ( -0.47%)

35,337.60 63.05 ( 0.18%)

46,931.02 -400.98 (-0.85%)

6,741.06 -76.23 (-1.12%)

50,848.14 635.87 (1.27%)

9,736.38 -40.70 (-0.42%)

88.65 -0.03 (-0.04%)

101.82 -0.15 (-0.14%)

115.54 -0.38 (-0.33%)

0.58 0.00 (-0.08%)